Tatva Chintan Pharma Chem Ltd. Investor Presentation

05 May 2023

1437.60

-2.58%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed Investor Presentation for the quarter and financial year ended 31 March 2023. The above information shall be made available on the website of the Company at www.tatvachintan.com.

pdf

Tatva Chintan Pharma Chem Ltd.

24 Jan 2023

1437.60

-2.58%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed Investor Presentation for the quarter and nine months ended 31 December 2022. The above information shall be made available on the website of the Company at www.tatvachintan.com.

pdf

Tatva Chintan Pharma Chem Ltd.

04 Nov 2022

1437.60

-2.58%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed Investor Presentation for the quarter and half year ended 30 September 2022. The above information shall be made available on the website of the Company at www.tatvachintan.com.

pdf

Tatva Chintan Pharma Chem Ltd.

25 Jul 2022

1437.60

-2.58%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed Investor Presentation for the quarter ended 30 June 2022. The above information shall be made available on the website of the Company at www.tatvachintan.com. This is for your information and records.

pdf

Tatva Chintan Pharma Chem Ltd.

25 Apr 2022

1437.60

-2.58%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed Investor Presentation for the quarter and year ended 31 March 2022. The above information is also being made available on the website of the Company at www.tatvachintan.com. This is for your information and records.

pdf

Tatva Chintan Pharma Chem Ltd.

18 Jan 2022

1437.60

-2.58%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We hereby enclosed Investor Presentation for the quarter and nine months ended December 31, 2021. The same will be uploaded on the Company's website. This is for your information and records.

pdf

Tatva Chintan Pharma Chem Ltd. Investor Presentation